134 related articles for article (PubMed ID: 22815056)
1. Mutations in Lyar and p53 are synergistically lethal in female mice.
Wang G; Fulkerson CM; Malek R; Ghassemifar S; Snyder PW; Mendrysa SM
Birth Defects Res A Clin Mol Teratol; 2012 Sep; 94(9):729-37. PubMed ID: 22815056
[TBL] [Abstract][Full Text] [Related]
2. Neural tube development requires the cooperation of p53- and Gadd45a-associated pathways.
Patterson AD; Hildesheim J; Fornace AJ; Hollander MC
Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):129-32. PubMed ID: 16470852
[TBL] [Abstract][Full Text] [Related]
3. Ly-1 antibody reactive clone is an important nucleolar protein for control of self-renewal and differentiation in embryonic stem cells.
Li H; Wang B; Yang A; Lu R; Wang W; Zhou Y; Shi G; Kwon SW; Zhao Y; Jin Y
Stem Cells; 2009 Jun; 27(6):1244-54. PubMed ID: 19489080
[TBL] [Abstract][Full Text] [Related]
4. Human cell growth regulator Ly-1 antibody reactive homologue accelerates processing of preribosomal RNA.
Miyazawa N; Yoshikawa H; Magae S; Ishikawa H; Izumikawa K; Terukina G; Suzuki A; Nakamura-Fujiyama S; Miura Y; Hayano T; Komatsu W; Isobe T; Takahashi N
Genes Cells; 2014 Apr; 19(4):273-86. PubMed ID: 24495227
[TBL] [Abstract][Full Text] [Related]
5. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.
Bouwman P; Drost R; Klijn C; Pieterse M; van der Gulden H; Song JY; Szuhai K; Jonkers J
J Pathol; 2011 May; 224(1):10-21. PubMed ID: 21404276
[TBL] [Abstract][Full Text] [Related]
6. Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects.
Harris MJ; Juriloff DM
Birth Defects Res A Clin Mol Teratol; 2007 Mar; 79(3):187-210. PubMed ID: 17177317
[TBL] [Abstract][Full Text] [Related]
7. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation.
Hakem R; de la Pompa JL; Elia A; Potter J; Mak TW
Nat Genet; 1997 Jul; 16(3):298-302. PubMed ID: 9207798
[TBL] [Abstract][Full Text] [Related]
8. Essential validation of gene trap mouse ES cell lines: a test case with the gene Ttrap.
Vermeire L; Ibrahimi A; Voet T; Umans L; Coddens K; Francis A; Van de Putte T; van Grunsven LA; Zwijsen A; Huylebroeck D; Nelles L
Int J Dev Biol; 2009; 53(7):1045-51. PubMed ID: 19598121
[TBL] [Abstract][Full Text] [Related]
9. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis.
Yuan X; Zhou Y; Casanova E; Chai M; Kiss E; Gröne HJ; Schütz G; Grummt I
Mol Cell; 2005 Jul; 19(1):77-87. PubMed ID: 15989966
[TBL] [Abstract][Full Text] [Related]
10. The p53 tumor suppressor gene and gene product.
Levine AJ
Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
[TBL] [Abstract][Full Text] [Related]
11. The roles of p53 and p21 in normal development and hyperthermia-induced malformations.
Hosako H; Francisco LE; Martin GS; Mirkes PE
Birth Defects Res B Dev Reprod Toxicol; 2009 Feb; 86(1):40-7. PubMed ID: 19140129
[TBL] [Abstract][Full Text] [Related]
12. Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function.
de Vries A; Flores ER; Miranda B; Hsieh HM; van Oostrom CT; Sage J; Jacks T
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2948-53. PubMed ID: 11867759
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the embryonic phenotype of Bent tail, a mouse model for X-linked neural tube defects.
Franke B; Klootwijk R; Hekking JW; de Boer RT; ten Donkelaar HJ; Mariman EC; van Straaten HW
Anat Embryol (Berl); 2003 Oct; 207(3):255-62. PubMed ID: 14523648
[TBL] [Abstract][Full Text] [Related]
14. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation.
Connor F; Bertwistle D; Mee PJ; Ross GM; Swift S; Grigorieva E; Tybulewicz VL; Ashworth A
Nat Genet; 1997 Dec; 17(4):423-30. PubMed ID: 9398843
[TBL] [Abstract][Full Text] [Related]
15. A subset of p53-deficient embryos exhibit exencephaly.
Sah VP; Attardi LD; Mulligan GJ; Williams BO; Bronson RT; Jacks T
Nat Genet; 1995 Jun; 10(2):175-80. PubMed ID: 7663512
[TBL] [Abstract][Full Text] [Related]
16. p53 Mutant p53
Zhao J; Tian Y; Zhang H; Qu L; Chen Y; Liu Q; Luo Y; Wu X
Int J Biol Sci; 2019; 15(9):2006-2015. PubMed ID: 31523200
[TBL] [Abstract][Full Text] [Related]
17. Gene and microRNA expression in p53-deficient day 8.5 mouse embryos.
Hosako H; Martin GS; Barrier M; Chen YA; Ivanov IV; Mirkes PE
Birth Defects Res A Clin Mol Teratol; 2009 Jun; 85(6):546-55. PubMed ID: 19229884
[TBL] [Abstract][Full Text] [Related]
18. An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure.
Harris MJ; Juriloff DM
Birth Defects Res A Clin Mol Teratol; 2010 Aug; 88(8):653-69. PubMed ID: 20740593
[TBL] [Abstract][Full Text] [Related]
19. LYAR, a novel nucleolar protein with zinc finger DNA-binding motifs, is involved in cell growth regulation.
Su L; Hershberger RJ; Weissman IL
Genes Dev; 1993 May; 7(5):735-48. PubMed ID: 8491376
[TBL] [Abstract][Full Text] [Related]
20. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
